The role of noncoding RNAs in the tumor microenvironment of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the leading fatal malignancy worldwide. The tumor microenvironment (TME) can affect the survival, proliferation, migration, and even dormancy of cancer cells. Hypoxia is an important component of the TME, and hypoxia-inducible factor-1α (HIF-1α) is the most importan...
Saved in:
Published in | Acta biochimica et biophysica Sinica Vol. 55; no. 11; pp. 1697 - 1706 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
China
China Science Publishing & Media Ltd
25.11.2023
|
Subjects | |
Online Access | Get full text |
ISSN | 1672-9145 1745-7270 1745-7270 |
DOI | 10.3724/abbs.2023231 |
Cover
Abstract | Hepatocellular carcinoma (HCC) is the leading fatal malignancy worldwide. The tumor microenvironment (TME) can affect the survival, proliferation, migration, and even dormancy of cancer cells. Hypoxia is an important component of the TME, and hypoxia-inducible factor-1α (HIF-1α) is the most important transcriptional regulator. Noncoding RNAs (ncRNAs), including microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs), comprise a large part of the human transcriptome and play an important role in regulating the tumorigenesis of HCC. This review discusses the role of ncRNAs in hepatocarcinogenesis, epithelial-mesenchymal transition (EMT), and angiogenesis in a hypoxic microenvironment, as well as the interactions between ncRNAs and key components of the TME. It further discusses their use as biomarkers and the potential clinical value of drugs, as well as the challenges faced in the future. |
---|---|
AbstractList | Hepatocellular carcinoma (HCC) is the leading fatal malignancy worldwide. The tumor microenvironment (TME) can affect the survival, proliferation, migration, and even dormancy of cancer cells. Hypoxia is an important component of the TME, and hypoxia-inducible factor-1α (HIF-1α) is the most important transcriptional regulator. Noncoding RNAs (ncRNAs), including microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs), comprise a large part of the human transcriptome and play an important role in regulating the tumorigenesis of HCC. This review discusses the role of ncRNAs in hepatocarcinogenesis, epithelial-mesenchymal transition (EMT), and angiogenesis in a hypoxic microenvironment, as well as the interactions between ncRNAs and key components of the TME. It further discusses their use as biomarkers and the potential clinical value of drugs, as well as the challenges faced in the future. Hepatocellular carcinoma (HCC) is the leading fatal malignancy worldwide. The tumor microenvironment (TME) can affect the survival, proliferation, migration, and even dormancy of cancer cells. Hypoxia is an important component of the TME, and hypoxia-inducible factor-1α (HIF-1α) is the most important transcriptional regulator. Noncoding RNAs (ncRNAs), including microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs), comprise a large part of the human transcriptome and play an important role in regulating the tumorigenesis of HCC. This review discusses the role of ncRNAs in hepatocarcinogenesis, epithelial-mesenchymal transition (EMT), and angiogenesis in a hypoxic microenvironment, as well as the interactions between ncRNAs and key components of the TME. It further discusses their use as biomarkers and the potential clinical value of drugs, as well as the challenges faced in the future.Hepatocellular carcinoma (HCC) is the leading fatal malignancy worldwide. The tumor microenvironment (TME) can affect the survival, proliferation, migration, and even dormancy of cancer cells. Hypoxia is an important component of the TME, and hypoxia-inducible factor-1α (HIF-1α) is the most important transcriptional regulator. Noncoding RNAs (ncRNAs), including microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs), comprise a large part of the human transcriptome and play an important role in regulating the tumorigenesis of HCC. This review discusses the role of ncRNAs in hepatocarcinogenesis, epithelial-mesenchymal transition (EMT), and angiogenesis in a hypoxic microenvironment, as well as the interactions between ncRNAs and key components of the TME. It further discusses their use as biomarkers and the potential clinical value of drugs, as well as the challenges faced in the future. |
Author | Yang, Qianqian Wang, Guangzhi Tian, Hui Ma, Zhongliang Guo, Ziyi |
Author_xml | – sequence: 1 givenname: Qianqian surname: Yang fullname: Yang, Qianqian – sequence: 2 givenname: Hui surname: Tian fullname: Tian, Hui – sequence: 3 givenname: Ziyi surname: Guo fullname: Guo, Ziyi – sequence: 4 givenname: Zhongliang surname: Ma fullname: Ma, Zhongliang – sequence: 5 givenname: Guangzhi surname: Wang fullname: Wang, Guangzhi |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37867435$$D View this record in MEDLINE/PubMed |
BookMark | eNptkctvFSEUh4mpsQ_duTazdOFUXjMwy6aptUmjSXO7JjwOLc0MXIEx8b8vt_fahXEFgY_vcM7vFB3FFAGhjwSfM0H5V21MOaeYMsrIG3RCBB96QQU-avtR0H4ifDhGp6U8YczGkeB36JgJOQrOhhO02TxCl9MMXfJdM9vkQnzo7n5clC7Errbbui4pd0uwOUH8HXKKC8S64x9hq2uyMM_rrHNndbYhpkW_R2-9ngt8OKxn6P7b1ebye3_78_rm8uK2t2waak8kAJFGGG6AjiApsaO0lmDq5eAEm7QENzoPhnPshJ0sN9Rgh4WfDGcTO0M3e69L-kltc1h0_qOSDurlIOUHpXMNdgbVHEYwT7XEnpPWvx1Gzq2d-CC8nVxzfd67tjn9WqFUtYSya01HSGtRVErcfijx0NBPB3Q1C7jXwn-n2oAve6CNrJQM_hUhWO1CU7vQ1CG0htN_cBuqriHFmnWY___oGegfmqs |
CitedBy_id | crossref_primary_10_3724_abbs_2024112 crossref_primary_10_2147_ITT_S463556 |
Cites_doi | 10.1002/hep.30795 10.3389/fimmu.2022.847728 10.1002/hep.30931 10.1038/s42003-018-0177-5 10.1038/s41388-018-0552-1 10.1007/s00018-019-03351-7 10.1002/ijc.31977 10.7150/ijbs.39582 10.1056/NEJM197111182852108 10.1096/fj.201901834R 10.3389/fphar.2018.01125 10.1186/s13046-020-1528-x 10.3390/cells11121948 10.1186/s13046-021-01868-z 10.1186/s12943-019-1113-0 10.1038/s41389-017-0011-9 10.1002/hep.28577 10.3892/ijo.2022.5374 10.1002/ijc.34040 10.1016/j.it.2019.02.003 10.1007/s10555-022-10071-1 10.1038/s41419-021-04449-2 10.1002/advs.201802070 10.1016/j.canlet.2020.11.007 10.1007/s00441-016-2527-2 10.1038/s41598-019-43759-6 10.1002/jcp.27095 10.1007/s10120-021-01213-5 10.1016/j.tips.2012.01.005 10.1074/jbc.M110.158485 10.1111/jcmm.15119 10.3390/cells11233857 10.1186/s13046-022-02478-z 10.1080/15384101.2022.2040283 10.1016/j.ajpath.2019.10.010 10.1038/aps.2012.195 10.3389/fimmu.2021.793343 10.1002/hep.25497 10.1002/jcp.26446 10.1186/s12943-019-1089-9 10.3322/caac.21708 10.3892/or.2019.7397 10.1155/2019/8983704 10.1177/1535370220934038 10.1038/s41419-022-04505-5 10.1007/s10555-007-9066-y 10.1186/s13046-020-1535-y 10.1186/s12943-023-01759-1 10.3390/ijms24054272 10.3892/mmr.2020.11304 10.1631/jzus.B1900452 10.1186/s11658-018-0077-1 10.1002/med.21511 10.1007/s13577-022-00800-7 10.1053/j.gastro.2021.10.015 10.1136/gutjnl-2017-315402 10.1007/s11095-007-9504-0 10.1007/s11912-019-0752-z 10.1111/jgh.15548 10.3390/ijms23031636 10.1245/s10434-022-11862-0 10.1155/2022/7318950 10.1016/j.yexcr.2021.112804 10.1038/s41467-022-28618-9 10.1371/journal.pone.0065753 10.1002/ijc.31953 10.3233/CBM-171075 10.1016/j.bbrc.2021.06.011 10.1515/biol-2022-0498 10.1038/s41388-022-02197-x 10.3390/ijms19123742 10.1186/s11658-019-0152-2 10.1016/j.gendis.2020.11.015 10.3390/ijms24054593 10.1089/dna.2020.5442 10.1038/s41392-020-00453-8 10.1371/journal.pone.0133074 10.3389/fonc.2022.961637 10.1038/s42003-020-01367-5 10.1007/s12094-021-02599-5 10.1186/s11658-022-00370-4 10.7150/ijbs.67556 10.1016/j.hbpd.2021.09.006 10.1177/15353702221108379 10.3390/ijms22147429 10.1016/j.drudis.2020.07.026 10.3389/fcell.2021.646864 10.1007/s00109-016-1408-1 10.1136/gutjnl-2021-324170 10.1002/cac2.12392 10.1016/j.canlet.2021.03.025 10.1186/s11658-022-00309-9 10.1016/j.intimp.2021.108288 10.1111/jcmm.15399 10.1007/s13402-022-00730-4 10.1186/s13046-020-01739-z 10.1080/21655979.2021.2018538 10.1016/j.yexcr.2020.112192 10.1016/j.ebiom.2019.06.048 10.1080/21655979.2021.2020549 10.1186/s12943-019-1019-x 10.1186/s13046-019-1398-2 10.1136/mp.51.2.55 10.3892/or.2018.6289 10.1159/000481246 10.1016/j.omtn.2019.11.007 10.1007/978-3-030-50224-9_1 10.1080/21655979.2021.2015530 10.1111/jcmm.15708 10.1038/nature06905 10.1016/j.lfs.2020.118819 10.1038/s41467-021-21535-3 10.1016/j.cbi.2021.109780 10.2174/1874467214666210120154929 10.1073/pnas.2023868118 10.1016/j.bbrc.2019.03.109 10.1038/nrn1408 10.18632/oncotarget.24623 |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 DOA |
DOI | 10.3724/abbs.2023231 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1745-7270 |
EndPage | 1706 |
ExternalDocumentID | oai_doaj_org_article_eb4b73f2a80f41378c5644cc9457fc9d 37867435 10_3724_abbs_2023231 |
Genre | Journal Article Review |
GroupedDBID | --- .2P .I3 1OC 1TH 23M 36B 4.4 48X 53G 5GY 5VR 5VS 6J9 70D AAIJN AAIMJ AAJKP AAMDB AAMVS AAOGV AAPQZ AAPXW AAVAP AAVLN AAYXX ABEJV ABEUO ABGNP ABIXL ABNKS ABQLI ABXVV ABZBJ ACGFO ACGFS ACUFI ACYTK ADBBV ADEYI ADFTL ADGZP ADHKW ADHZD ADOCK ADRTK ADYVW ADZTZ ADZXQ AECKG AEGPL AEGXH AEJOX AEKKA AEKSI AELWJ AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFOFC AGINJ AGKEF AGSYK AHXPO AIJHB AJEUX AKHUL AKWXX ALMA_UNASSIGNED_HOLDINGS ALTZX ALUQC APIBT APWMN ARIXL AXUDD AYOIW AZVOD BAWUL BAYMD BHONS BQDIO BQUQU BSWAC BTQHN CDBKE CITATION CS3 CZ4 DAKXR DIK DILTD D~K E3Z EBS EE~ EMB EMOBN F5P F9B FHSFR FLIZI FLUFQ FOEOM FQBLK GAUVT GJXCC GROUPED_DOAJ GX1 H5~ HAR HW0 HZ~ IOX J21 JXSIZ KOP KSI KSN M-Z N9A NGC NLBLG NMDNZ O9- OAWHX ODMLO OJQWA OK1 PAFKI PEELM Q1. Q5Y RD5 RPM RUSNO RW1 RXO SV3 TJP TLC W2D X7H YAYTL YKOAZ YXANX ~91 188 CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c395t-18ee18b7b4be26e821c68cc102f85d739a8ed6dfeb440d7c9c4b2b0d07f9b4393 |
IEDL.DBID | DOA |
ISSN | 1672-9145 1745-7270 |
IngestDate | Wed Aug 27 01:26:04 EDT 2025 Fri Jul 11 10:55:14 EDT 2025 Thu Apr 03 07:04:11 EDT 2025 Thu Apr 24 23:10:24 EDT 2025 Tue Jul 01 04:20:40 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | HIF-1α tumor microenvironment noncoding RNAs hepatocellular carcinoma |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c395t-18ee18b7b4be26e821c68cc102f85d739a8ed6dfeb440d7c9c4b2b0d07f9b4393 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
OpenAccessLink | https://doaj.org/article/eb4b73f2a80f41378c5644cc9457fc9d |
PMID | 37867435 |
PQID | 2880821805 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_eb4b73f2a80f41378c5644cc9457fc9d proquest_miscellaneous_2880821805 pubmed_primary_37867435 crossref_primary_10_3724_abbs_2023231 crossref_citationtrail_10_3724_abbs_2023231 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-11-25 |
PublicationDateYYYYMMDD | 2023-11-25 |
PublicationDate_xml | – month: 11 year: 2023 text: 2023-11-25 day: 25 |
PublicationDecade | 2020 |
PublicationPlace | China |
PublicationPlace_xml | – name: China |
PublicationTitle | Acta biochimica et biophysica Sinica |
PublicationTitleAlternate | Acta Biochim Biophys Sin (Shanghai) |
PublicationYear | 2023 |
Publisher | China Science Publishing & Media Ltd |
Publisher_xml | – name: China Science Publishing & Media Ltd |
References | Jing X (CITATION19) 2019; 18 Goyette MA (CITATION20) 2021; 118 Chen Q (CITATION104) 2021; 9 Peng D (CITATION44) 2022; 355 Ren S (CITATION88) 2019; 38 Hu Z (CITATION111) 2023; 22 Chen T (CITATION34) 2021; 12 Rius J (CITATION63) 2008; 453 Zhang MS (CITATION17) 2022; 13 Chen Y (CITATION2) 2008; 25 Zeng C (CITATION46) 2022; 13 Zhang QJ (CITATION93) 2022; 21 Lu L (CITATION82) 2022; 27 Sharp FR (CITATION10) 2004; 5 Piao H (CITATION43) 2022; 25 Dutta A (CITATION106) 2021; 26 Wang Y (CITATION92) 2022; 247 Malla RR (CITATION61) 2022; 9 Hu JL (CITATION80) 2019; 18 Lugano R (CITATION99) 2020; 77 Feng J (CITATION30) 2020; 39 Shi Y (CITATION21) 2021; 40 Chen Y (CITATION24) 2019; 6 Long Q (CITATION38) 2019; 513 Liao W (CITATION7) 2022; 151 Ju C (CITATION11) 2016; 94 Chua YL (CITATION13) 2010; 285 Hu Y (CITATION74) 2020; 24 Chen C (CITATION105) 2020; 21 Zhang P (CITATION102) 2020; 34 Nishida N (CITATION114) 2017; 93 Satija S (CITATION9) 2021; 14 Dietrich P (CITATION116) 2018; 67 CITATION47 Zhang L (CITATION51) 2022; 13 Zhang P (CITATION117) 2019; 234 Meng H (CITATION8) 2022; 11 Xu T (CITATION91) 2020; 24 Liao D (CITATION98) 2007; 26 Teng F (CITATION101) 2020; 39 Wang L (CITATION56) 2021; 40 CITATION53 Liu N (CITATION110) 2022; 162 Wu Y (CITATION103) 2021; 408 Semenza GL (CITATION6) 2012; 33 Kashima H (CITATION77) 2019; 144 Yang J (CITATION89) 2023; 55 Royds JA (CITATION62) 1998; 51 Pathria P (CITATION107) 2019; 40 CITATION4 Xie C (CITATION70) 2020; 71 CITATION67 CITATION1 Li Q (CITATION35) 2021; 6 Wei Y (CITATION118) 2020; 71 Chen Z (CITATION52) 2022; 18 Chen X (CITATION16) 2020; 395 Kato K (CITATION78) 2022; 29 Liu G (CITATION79) 2022; 45 Wang T (CITATION90) 2019; 45 Jurado Acosta A (CITATION87) 2017; 367 Eun JW (CITATION85) 2023; 24 Guo J (CITATION100) 2022; 17 Wu ZH (CITATION81) 2021; 12 Huang YH (CITATION45) 2022; 23 Lachowski D (CITATION86) 2019; 9 Wang Q (CITATION48) 2021; 266 Shen G (CITATION41) 2013; 34 Wei H (CITATION54) 2022; 13 CITATION71 CITATION72 Yang C (CITATION65) 2020; 24 Ma H (CITATION29) 2018; 1 Zheng F (CITATION55) 2021; 12 Liu Z (CITATION40) 2018; 22 Zhang J (CITATION50) 2022; 21 Peng X (CITATION14) 2020; 39 Byun Y (CITATION49) 2019; 24 Fang Z (CITATION59) 2023; 43 Liu X (CITATION69) 2020; 19 Liu A (CITATION57) 2021; 23 Wang X (CITATION42) 2021; 499 CITATION109 Wang K (CITATION113) 2018; 9 Lin YH (CITATION39) 2018; 19 Zhang J (CITATION112) 2022; 41 Nath B (CITATION15) 2012; 55 Fathi M (CITATION18) 2021; 101 Xue C (CITATION3) 2022; 13 Ocaña MC (CITATION25) 2019; 39 Chen G (CITATION22) 2022; 12 Seo J (CITATION31) 2020; 3 CITATION96 Huang T (CITATION66) 2020; 22 Zhao L (CITATION75) 2018; 233 CITATION97 Petrova V (CITATION115) 2018; 7 Yu H (CITATION108) 2023; 24 CITATION95 Wen J (CITATION73) 2022; 27 Chang H (CITATION37) 2021; 36 CITATION12 Ma Z (CITATION60) 2020; 19 Mohan CD (CITATION68) 2018; 9 Han L (CITATION28) 2022; 41 Roy S (CITATION5) 2020; 245 Zeng Z (CITATION32) 2021; 566 Chen R (CITATION76) 2020; 16 Kai AK (CITATION94) 2016; 64 Feng W (CITATION33) 2018; 23 Martin M (CITATION58) 2021; 22 CITATION27 Feng Q (CITATION64) 2020; 190 Qi Y (CITATION83) 2022; 11 Zhang Y (CITATION84) 2023; 36 Wen Y (CITATION36) 2019; 38 CITATION23 CITATION26 Fallah J (CITATION119) 2019; 21 |
References_xml | – volume: 71 start-page: 130 year: 2020 ident: CITATION118 publication-title: Hepatology doi: 10.1002/hep.30795 – volume: 13 start-page: 847728 year: 2022 ident: CITATION3 publication-title: Front Immunol doi: 10.3389/fimmu.2022.847728 – volume: 71 start-page: 1660 year: 2020 ident: CITATION70 publication-title: Hepatology doi: 10.1002/hep.30931 – volume: 1 start-page: 168 year: 2018 ident: CITATION29 publication-title: Commun Biol doi: 10.1038/s42003-018-0177-5 – volume: 38 start-page: 1845 year: 2019 ident: CITATION36 publication-title: Oncogene doi: 10.1038/s41388-018-0552-1 – volume: 77 start-page: 1745 year: 2020 ident: CITATION99 publication-title: Cell Mol Life Sci doi: 10.1007/s00018-019-03351-7 – volume: 55 start-page: 809 year: 2023 ident: CITATION89 publication-title: Acta Biochim Biophys Sin doi: 10.1002/ijc.31977 – volume: 16 start-page: 495 year: 2020 ident: CITATION76 publication-title: Int J Biol Sci doi: 10.7150/ijbs.39582 – ident: CITATION97 doi: 10.1056/NEJM197111182852108 – volume: 34 start-page: 66 year: 2020 ident: CITATION102 publication-title: FASEB J doi: 10.1096/fj.201901834R – volume: 9 start-page: 1125 year: 2018 ident: CITATION68 publication-title: Front Pharmacol doi: 10.3389/fphar.2018.01125 – volume: 39 start-page: 24 year: 2020 ident: CITATION30 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-020-1528-x – volume: 11 start-page: 1948 year: 2022 ident: CITATION8 publication-title: Cells doi: 10.3390/cells11121948 – volume: 40 start-page: 72 year: 2021 ident: CITATION56 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-021-01868-z – ident: CITATION71 – volume: 19 start-page: 8 year: 2020 ident: CITATION60 publication-title: Mol Cancer doi: 10.1186/s12943-019-1113-0 – volume: 7 start-page: 10 year: 2018 ident: CITATION115 publication-title: Oncogenesis doi: 10.1038/s41389-017-0011-9 – volume: 64 start-page: 473 year: 2016 ident: CITATION94 publication-title: Hepatology doi: 10.1002/hep.28577 – ident: CITATION4 doi: 10.3892/ijo.2022.5374 – volume: 151 start-page: 337 year: 2022 ident: CITATION7 publication-title: Intl J Cancer doi: 10.1002/ijc.34040 – volume: 40 start-page: 310 year: 2019 ident: CITATION107 publication-title: Trends Immunol doi: 10.1016/j.it.2019.02.003 – ident: CITATION23 doi: 10.1007/s10555-022-10071-1 – volume: 12 start-page: 1152 year: 2021 ident: CITATION34 publication-title: Cell Death Dis doi: 10.1038/s41419-021-04449-2 – volume: 6 start-page: 1802070 year: 2019 ident: CITATION24 publication-title: Adv Sci doi: 10.1002/advs.201802070 – volume: 499 start-page: 49 year: 2021 ident: CITATION42 publication-title: Cancer Lett doi: 10.1016/j.canlet.2020.11.007 – volume: 367 start-page: 369 year: 2017 ident: CITATION87 publication-title: Cell Tissue Res doi: 10.1007/s00441-016-2527-2 – volume: 9 start-page: 7299 year: 2019 ident: CITATION86 publication-title: Sci Rep doi: 10.1038/s41598-019-43759-6 – volume: 234 start-page: 2788 year: 2019 ident: CITATION117 publication-title: J Cell Physiol doi: 10.1002/jcp.27095 – volume: 25 start-page: 44 year: 2022 ident: CITATION43 publication-title: Gastric Cancer doi: 10.1007/s10120-021-01213-5 – volume: 33 start-page: 207 year: 2012 ident: CITATION6 publication-title: Trends Pharmacol Sci doi: 10.1016/j.tips.2012.01.005 – volume: 285 start-page: 31277 year: 2010 ident: CITATION13 publication-title: J Biol Chem doi: 10.1074/jbc.M110.158485 – volume: 24 start-page: 7127 year: 2020 ident: CITATION91 publication-title: J Cell Mol Medi doi: 10.1111/jcmm.15119 – volume: 11 start-page: 3857 year: 2022 ident: CITATION83 publication-title: Cells doi: 10.3390/cells11233857 – volume: 41 start-page: 270 year: 2022 ident: CITATION112 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-022-02478-z – volume: 21 start-page: 1034 year: 2022 ident: CITATION50 publication-title: Cell Cycle doi: 10.1080/15384101.2022.2040283 – volume: 190 start-page: 469 year: 2020 ident: CITATION64 publication-title: Am J Pathol doi: 10.1016/j.ajpath.2019.10.010 – volume: 34 start-page: 336 year: 2013 ident: CITATION41 publication-title: Acta Pharmacol Sin doi: 10.1038/aps.2012.195 – volume: 12 start-page: 793343 year: 2021 ident: CITATION81 publication-title: Front Immunol doi: 10.3389/fimmu.2021.793343 – volume: 55 start-page: 622 year: 2012 ident: CITATION15 publication-title: Hepatology doi: 10.1002/hep.25497 – volume: 233 start-page: 6661 year: 2018 ident: CITATION75 publication-title: J Cell Physiol doi: 10.1002/jcp.26446 – volume: 18 start-page: 157 year: 2019 ident: CITATION19 publication-title: Mol Cancer doi: 10.1186/s12943-019-1089-9 – ident: CITATION1 doi: 10.3322/caac.21708 – ident: CITATION12 doi: 10.3892/or.2019.7397 – ident: CITATION27 doi: 10.1155/2019/8983704 – volume: 245 start-page: 1073 year: 2020 ident: CITATION5 publication-title: Exp Biol Med (Maywood) doi: 10.1177/1535370220934038 – volume: 13 start-page: 102 year: 2022 ident: CITATION54 publication-title: Cell Death Dis doi: 10.1038/s41419-022-04505-5 – volume: 26 start-page: 281 year: 2007 ident: CITATION98 publication-title: Cancer Metastasis Rev doi: 10.1007/s10555-007-9066-y – volume: 39 start-page: 27 year: 2020 ident: CITATION14 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-020-1535-y – volume: 22 start-page: 55 year: 2023 ident: CITATION111 publication-title: Mol Cancer doi: 10.1186/s12943-023-01759-1 – volume: 24 start-page: 4272 year: 2023 ident: CITATION85 publication-title: Int J Mol Sci doi: 10.3390/ijms24054272 – volume: 22 start-page: 2386 year: 2020 ident: CITATION66 publication-title: Mol Med Rep doi: 10.3892/mmr.2020.11304 – volume: 21 start-page: 12 year: 2020 ident: CITATION105 publication-title: J Zhejiang Univ Sci B doi: 10.1631/jzus.B1900452 – volume: 23 start-page: 26 year: 2018 ident: CITATION33 publication-title: Cell Mol Biol Lett doi: 10.1186/s11658-018-0077-1 – volume: 39 start-page: 70 year: 2019 ident: CITATION25 publication-title: Medicinal Res Rev doi: 10.1002/med.21511 – volume: 36 start-page: 296 year: 2023 ident: CITATION84 publication-title: Hum Cell doi: 10.1007/s13577-022-00800-7 – volume: 162 start-page: 575 year: 2022 ident: CITATION110 publication-title: Gastroenterology doi: 10.1053/j.gastro.2021.10.015 – volume: 67 start-page: 1328 year: 2018 ident: CITATION116 publication-title: Gut doi: 10.1136/gutjnl-2017-315402 – volume: 25 start-page: 72 year: 2008 ident: CITATION2 publication-title: Pharm Res doi: 10.1007/s11095-007-9504-0 – volume: 21 start-page: 6 year: 2019 ident: CITATION119 publication-title: Curr Oncol Rep doi: 10.1007/s11912-019-0752-z – volume: 36 start-page: 2978 year: 2021 ident: CITATION37 publication-title: J Gastro Hepatol doi: 10.1111/jgh.15548 – volume: 23 start-page: 1636 year: 2022 ident: CITATION45 publication-title: Int J Mol Sci doi: 10.3390/ijms23031636 – volume: 29 start-page: 7135 year: 2022 ident: CITATION78 publication-title: Ann Surg Oncol doi: 10.1245/s10434-022-11862-0 – ident: CITATION47 doi: 10.1155/2022/7318950 – volume: 408 start-page: 112804 year: 2021 ident: CITATION103 publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2021.112804 – volume: 13 start-page: 954 year: 2022 ident: CITATION17 publication-title: Nat Commun doi: 10.1038/s41467-022-28618-9 – ident: CITATION26 doi: 10.1371/journal.pone.0065753 – volume: 144 start-page: 828 year: 2019 ident: CITATION77 publication-title: Intl J Cancer doi: 10.1002/ijc.31953 – volume: 22 start-page: 453 year: 2018 ident: CITATION40 publication-title: Cancer Biomark doi: 10.3233/CBM-171075 – volume: 566 start-page: 80 year: 2021 ident: CITATION32 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2021.06.011 – volume: 17 start-page: 1229 year: 2022 ident: CITATION100 publication-title: Open Life Sci doi: 10.1515/biol-2022-0498 – volume: 41 start-page: 1851 year: 2022 ident: CITATION28 publication-title: Oncogene doi: 10.1038/s41388-022-02197-x – volume: 19 start-page: 3742 year: 2018 ident: CITATION39 publication-title: Int J Mol Sci doi: 10.3390/ijms19123742 – volume: 24 start-page: 28 year: 2019 ident: CITATION49 publication-title: Cell Mol Biol Lett doi: 10.1186/s11658-019-0152-2 – volume: 9 start-page: 310 year: 2022 ident: CITATION61 publication-title: Genes Dis doi: 10.1016/j.gendis.2020.11.015 – volume: 24 start-page: 4593 year: 2023 ident: CITATION108 publication-title: Int J Mol Sci doi: 10.3390/ijms24054593 – volume: 40 start-page: 93 year: 2021 ident: CITATION21 publication-title: DNA Cell Biol doi: 10.1089/dna.2020.5442 – volume: 6 start-page: 76 year: 2021 ident: CITATION35 publication-title: Sig Transduct Target Ther doi: 10.1038/s41392-020-00453-8 – ident: CITATION95 doi: 10.1371/journal.pone.0133074 – volume: 12 start-page: 961637 year: 2022 ident: CITATION22 publication-title: Front Oncol doi: 10.3389/fonc.2022.961637 – volume: 3 start-page: 638 year: 2020 ident: CITATION31 publication-title: Commun Biol doi: 10.1038/s42003-020-01367-5 – volume: 23 start-page: 1905 year: 2021 ident: CITATION57 publication-title: Clin Transl Oncol doi: 10.1007/s12094-021-02599-5 – volume: 27 start-page: 79 year: 2022 ident: CITATION73 publication-title: Cell Mol Biol Lett doi: 10.1186/s11658-022-00370-4 – volume: 18 start-page: 522 year: 2022 ident: CITATION52 publication-title: Int J Biol Sci doi: 10.7150/ijbs.67556 – volume: 21 start-page: 41 year: 2022 ident: CITATION93 publication-title: Hepatobiliary Pancreatic Dis Int doi: 10.1016/j.hbpd.2021.09.006 – volume: 247 start-page: 1712 year: 2022 ident: CITATION92 publication-title: Exp Biol Med (Maywood) doi: 10.1177/15353702221108379 – volume: 22 start-page: 7429 year: 2021 ident: CITATION58 publication-title: Int J Mol Sci doi: 10.3390/ijms22147429 – volume: 26 start-page: 264 year: 2021 ident: CITATION106 publication-title: Drug Discov Today doi: 10.1016/j.drudis.2020.07.026 – volume: 9 start-page: 646864 year: 2021 ident: CITATION104 publication-title: Front Cell Dev Biol doi: 10.3389/fcell.2021.646864 – volume: 94 start-page: 613 year: 2016 ident: CITATION11 publication-title: J Mol Med doi: 10.1007/s00109-016-1408-1 – ident: CITATION109 doi: 10.1136/gutjnl-2021-324170 – volume: 43 start-page: 3 year: 2023 ident: CITATION59 publication-title: Cancer Commun doi: 10.1002/cac2.12392 – ident: CITATION67 doi: 10.1016/j.canlet.2021.03.025 – volume: 27 start-page: 17 year: 2022 ident: CITATION82 publication-title: Cell Mol Biol Lett doi: 10.1186/s11658-022-00309-9 – volume: 101 start-page: 108288 year: 2021 ident: CITATION18 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2021.108288 – volume: 24 start-page: 7637 year: 2020 ident: CITATION74 publication-title: J Cell Mol Medi doi: 10.1111/jcmm.15399 – volume: 45 start-page: 1435 year: 2022 ident: CITATION79 publication-title: Cell Oncol doi: 10.1007/s13402-022-00730-4 – volume: 39 start-page: 235 year: 2020 ident: CITATION101 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-020-01739-z – ident: CITATION53 doi: 10.1080/21655979.2021.2018538 – volume: 395 start-page: 112192 year: 2020 ident: CITATION16 publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2020.112192 – volume: 45 start-page: 168 year: 2019 ident: CITATION90 publication-title: EBioMedicine doi: 10.1016/j.ebiom.2019.06.048 – volume: 13 start-page: 1491 year: 2022 ident: CITATION46 publication-title: Bioengineered doi: 10.1080/21655979.2021.2020549 – volume: 18 start-page: 91 year: 2019 ident: CITATION80 publication-title: Mol Cancer doi: 10.1186/s12943-019-1019-x – volume: 38 start-page: 388 year: 2019 ident: CITATION88 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-019-1398-2 – volume: 51 start-page: 55 year: 1998 ident: CITATION62 publication-title: Mol Pathol doi: 10.1136/mp.51.2.55 – ident: CITATION72 doi: 10.3892/or.2018.6289 – volume: 93 start-page: 160 year: 2017 ident: CITATION114 publication-title: Oncology doi: 10.1159/000481246 – volume: 19 start-page: 208 year: 2020 ident: CITATION69 publication-title: Mol Ther Nucleic Acids doi: 10.1016/j.omtn.2019.11.007 – ident: CITATION96 doi: 10.1007/978-3-030-50224-9_1 – volume: 13 start-page: 950 year: 2022 ident: CITATION51 publication-title: Bioengineered doi: 10.1080/21655979.2021.2015530 – volume: 24 start-page: 10830 year: 2020 ident: CITATION65 publication-title: J Cell Mol Medi doi: 10.1111/jcmm.15708 – volume: 453 start-page: 807 year: 2008 ident: CITATION63 publication-title: Nature doi: 10.1038/nature06905 – volume: 266 start-page: 118819 year: 2021 ident: CITATION48 publication-title: Life Sci doi: 10.1016/j.lfs.2020.118819 – volume: 12 start-page: 1341 year: 2021 ident: CITATION55 publication-title: Nat Commun doi: 10.1038/s41467-021-21535-3 – volume: 355 start-page: 109780 year: 2022 ident: CITATION44 publication-title: Chemico-Biol Interactions doi: 10.1016/j.cbi.2021.109780 – volume: 14 start-page: 321 year: 2021 ident: CITATION9 publication-title: Curr Mol Pharmacol doi: 10.2174/1874467214666210120154929 – volume: 118 start-page: e2023868118 year: 2021 ident: CITATION20 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.2023868118 – volume: 513 start-page: 642 year: 2019 ident: CITATION38 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2019.03.109 – volume: 5 start-page: 437 year: 2004 ident: CITATION10 publication-title: Nat Rev Neurosci doi: 10.1038/nrn1408 – volume: 9 start-page: 23306 year: 2018 ident: CITATION113 publication-title: Oncotarget doi: 10.18632/oncotarget.24623 |
SSID | ssj0036610 |
Score | 2.3628511 |
SecondaryResourceType | review_article |
Snippet | Hepatocellular carcinoma (HCC) is the leading fatal malignancy worldwide. The tumor microenvironment (TME) can affect the survival, proliferation, migration,... |
SourceID | doaj proquest pubmed crossref |
SourceType | Open Website Aggregation Database Index Database Enrichment Source |
StartPage | 1697 |
SubjectTerms | Biomarkers Carcinogenesis Carcinoma, Hepatocellular - pathology Gene Expression Regulation, Neoplastic hepatocellular carcinoma HIF-1α Humans Hypoxia Hypoxia-Inducible Factor 1, alpha Subunit Liver Neoplasms - pathology MicroRNAs - genetics noncoding RNAs RNA, Long Noncoding - genetics tumor microenvironment Tumor Microenvironment - genetics |
Title | The role of noncoding RNAs in the tumor microenvironment of hepatocellular carcinoma |
URI | https://www.ncbi.nlm.nih.gov/pubmed/37867435 https://www.proquest.com/docview/2880821805 https://doaj.org/article/eb4b73f2a80f41378c5644cc9457fc9d |
Volume | 55 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NS-UwEA-LIHiR9Wt96wdZcE9LMW2SJjmqKOqih0XBW0kmCbuw71XcvoP_vTNt38M9iBevZWjSXyYzvzTzwdiRheQzOqYiWp-oqLYvKLWniNq57EG7GOlG9-a2vrxX1w_64VWrL4oJG8oDD8Adp6CCkbnyVmQ0uMaCRhcO4JQ2GVwk6yucWBymBhss0ev0qZC1qXA7Kz2EvEtTKerRRWW6kUnI8j9n1Nfsf5to9g7n4jNbH5kiPxlmuME-pdkmWx16Rz5vsTtcYE6xgbzNHM_w0JIX4r9uT_7xPzOOvI5382n7xKcUcvcqn43kf6MT6lr6aU9RqByoodCsnfptdn9xfnd2WYwtEgqQTndFaVMqbTAIUqrqZKsSaguArCFbHY103qZYx4woKhENOFChCiIKk11ALiJ32ApOMe0ynm1lQFgQXiaVFQQbBcQIQcoyeWEn7McCqwbG-uHUxuJvg-cIQrYhZJsR2Qn7vpR-HOpmvCF3SrAvZajadf8AdaAZdaB5Twcm7Nti0RrcHYSen6V2jqOgeUJQrNAT9mVYzeVQ-B7KwNBfP2IKe2yNvoiyFCu9z1a6p3k6QLrShUPUzKufh71-vgAzDOjK |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+role+of+noncoding+RNAs+in+the+tumor+microenvironment+of+hepatocellular+carcinoma&rft.jtitle=Acta+biochimica+et+biophysica+Sinica&rft.au=Yang%2C+Qianqian&rft.au=Tian%2C+Hui&rft.au=Guo%2C+Ziyi&rft.au=Ma%2C+Zhongliang&rft.date=2023-11-25&rft.issn=1745-7270&rft.eissn=1745-7270&rft.volume=55&rft.issue=11&rft.spage=1697&rft_id=info:doi/10.3724%2Fabbs.2023231&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1672-9145&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1672-9145&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1672-9145&client=summon |